We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
3sfc
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='3sfc' size='340' side='right'caption='[[3sfc]], [[Resolution|resolution]] 2.10Å' scene=''> | <StructureSection load='3sfc' size='340' side='right'caption='[[3sfc]], [[Resolution|resolution]] 2.10Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3sfc]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3sfc]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SFC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3SFC FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=S53:[7-BENZYL-2-(5-FLUORO-2-METHYLPHENOXY)-1-PHENYL-1H-PYRROLO[2,3-C]PYRIDIN-3-YL](PIPERAZIN-1-YL)METHANONE'>S53</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=S53:[7-BENZYL-2-(5-FLUORO-2-METHYLPHENOXY)-1-PHENYL-1H-PYRROLO[2,3-C]PYRIDIN-3-YL](PIPERAZIN-1-YL)METHANONE'>S53</scene></td></tr> | |
| - | + | ||
| - | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3sfc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3sfc OCA], [https://pdbe.org/3sfc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3sfc RCSB], [https://www.ebi.ac.uk/pdbsum/3sfc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3sfc ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3sfc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3sfc OCA], [https://pdbe.org/3sfc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3sfc RCSB], [https://www.ebi.ac.uk/pdbsum/3sfc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3sfc ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | + | [https://www.uniprot.org/uniprot/RENI_HUMAN RENI_HUMAN] Defects in REN are a cause of renal tubular dysgenesis (RTD) [MIM:[https://omim.org/entry/267430 267430]. RTD is an autosomal recessive severe disorder of renal tubular development characterized by persistent fetal anuria and perinatal death, probably due to pulmonary hypoplasia from early-onset oligohydramnios (the Potter phenotype).<ref>PMID:16116425</ref> Defects in REN are the cause of familial juvenile hyperuricemic nephropathy type 2 (HNFJ2) [MIM:[https://omim.org/entry/613092 613092]. It is a renal disease characterized by juvenile onset of hyperuricemia, slowly progressive renal failure and anemia.<ref>PMID:19664745</ref> | |
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/RENI_HUMAN RENI_HUMAN] Renin is a highly specific endopeptidase, whose only known function is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney. | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 30: | Line 28: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | + | [[Category: Bocskei Z]] | |
| - | [[Category: Bocskei | + | [[Category: Fleury V]] |
| - | [[Category: Fleury | + | [[Category: Matter H]] |
| - | [[Category: Matter | + | [[Category: McCort G]] |
| - | [[Category: McCort | + | [[Category: Scheiper B]] |
| - | [[Category: Scheiper | + | [[Category: Steinhagen H]] |
| - | [[Category: Steinhagen | + | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors
| |||||||||||
